Biotech

All Articles

Bicara, Zenas find IPOs to drive late-phase properties towards market

.Bicara Therapies and also Zenas Biopharma have actually delivered clean catalyst to the IPO market ...

Genentech to shut cancer immunology research department

.Genentech is going to shut its cancer immunology analysis department, and unit head as well as popu...

Kezar loses strong growth yet to show its really worth in period 1 trial

.Kezar Life Sciences is actually losing its unpromising phase 1 solid cyst drug as the biotech goes ...

Acelyrin falls izokibep, dismisses 3rd of team

.Even with izokibep preserving its own newfound winning streak in the medical clinic, Acelyrin is no...

Rivus' phase 2 obesity-related cardiac arrest trial attacks endpoint

.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing drug prospect...

Ovid halts preclinical work, IV program after soticlestat fail

.Ovid Therapy already exposed last month that it was actually trimming back its headcount as the pro...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has opened up a $700 million R&ampD center in the Boston ma Port, improving its RNA and a...

Boundless Bio creates 'moderate' layoffs 5 months after $100M IPO

.Just 5 months after protecting a $100 thousand IPO, Boundless Biography is actually already laying ...

Halda's $126M is going to advance 'secure as well as get rid of' lump medications

.The initial stages of oncology R&ampD aren't short of appealing new techniques, and also Halda Ther...

Lykos 'remorses' not making known research violations along with author

.Psychopharmacology has taken 3 articles concerning midstage professional test information assessing...